Starling Oncology, Inc. Debt Instrument, Decrease, Forgiveness
Starling Oncology, Inc. (STLN) reported Debt Instrument, Decrease, Forgiveness of $5.14 million for the 12-month period ending 2021-12-31, per its 10-Q filed 2022-11-09.
Discontinued › Notes › Debt
us-gaap:DebtInstrumentDecreaseForgiveness · last filed 2022-11-09
| Period end | Debt Instrument, Decrease, Forgiveness 12 month |
|---|---|
| 2021-12-31 | $5.14M 10-Q · filed 2022-11-09 |